Genetic Technologies Genetic Technologies Inks US Commercialization Deal for COVID-19 Risk Test With Infinity Biologix The test is designed to assess the risk of a person developing severe disease if they contract COVID-19 based on a combination of genetic and clinical factors. Genetic Technologies to Raise $6.6M in Direct Offering The company said it had signed definitive agreements to sell $6.6 million of its American Depository Shares to undisclosed institutional investors. Genetic Technologies Lands Distribution Rights to Taliaz Antidepressant Drug Selection Tools The products analyze various datasets including a patient's genetic and metabolic profiles, clinical history, and demographics to inform prescribing decisions. Genetic Technologies Regains Compliance With Rules for Nasdaq Listing The Australian molecular diagnostics firm had stockholders' equity in excess of $2.5 million as of Aug. 28, in compliance with the Nasdaq listing rule. Genetic Technologies to Raise $5.1M in Direct Offering The Australian molecular diagnostics firm said it has signed agreements sell 1,025,000 of its American Depository Shares to several institutional investors. May 26, 2020 Genetic Technologies Prices $8M Public Offering Apr 20, 2020 Genetic Technologies Prices $1.4M Direct Offering Apr 1, 2020 Genetic Technologies Inks Deals to Raise A$1.8M Mar 16, 2020 Genetic Technologies Receives Nasdaq Delisting Notification May 22, 2019 Genetic Technologies Offers $1.2M in American Depository Shares May 3, 2019 Genetic Technologies Out of Compliance With Nasdaq Listing Rules Apr 15, 2019 Genetic Technologies, TGen to Launch Genetic Tests in US Feb 1, 2019 Genetic Technologies, Cancer Centers to Study Breast Cancer Polygenic Risk Score Impact Dec 21, 2018 In Brief This Week: QuantuMDx, Molbio, Seegene, Qiagen, Epigenomics, More Aug 16, 2018 Genetic Technologies Announces Planned Chinese Joint Venture Aug 8, 2018 Genetic Technologies Inks A$20M Equity Placement Deal Jul 30, 2018 Genetic Technologies, Swisstec Ink Asian Distribution Deal Jun 19, 2018 Genetic Technologies, Swisstec Reach Deal on JV Mar 16, 2018 Genetic Technologies, University of Melbourne Partner on Breast Cancer Risk Test Mar 6, 2018 Genetic Technologies Partners With Blockchain Group Project Shivom Feb 15, 2018 Genetic Technologies Eyes A$4.5M Private Placement; Explores Blockchain Partnership Jan 29, 2018 Genetic Technologies Reports Decline in Cash Receipts for Fiscal Q2 Jan 9, 2018 Genetic Technologies Regains Compliance With Nasdaq Listing Rules Dec 12, 2017 Genetic Technologies Faces Shareholder Revolt as It Mulls Strategic Alternatives Aug 25, 2017 Genetic Technologies Exploring Strategic Alternatives Load More Breaking News Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel Type 1 Diabetes GWAS, Fine-Mapping Leads to New Genetic Loci, Potential Drug Targets LSU Health Sciences Center Wins $2.4M to Lead SARS-CoV-2 Variant Sequencing Program NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project BGI Americas Collaborating With Champions Oncology on Proteomic Cancer Research Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System The Scan Missed Early Cases A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports. Limited Journal Editor Diversity A survey finds low diversity among scientific and medical journal editors, according to The Scientist. How Much of a Threat? Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned. PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.